TSX : APS.TO

Aptose Biosciences Inc.

$2.4 CAD

$0 (0.0%)

Volume
2.94K
Average Volume
2.78K
Market Capitalization
$6.13M
P/E Ratio
-0.16
Dividend Yield
0.00%
Price Target
Year High
$2.48
Year Low
$1.41
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.55
Source Headline

Get APS.TO Insider Trade Alerts

APS.TO Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

APS.TO Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2025-03-28 HC Wainwright & Co. Maintain Buy Buy
2025-02-12 HC Wainwright & Co. Maintain Buy Buy
2025-01-10 HC Wainwright & Co. Maintain Buy Buy
2024-12-10 HC Wainwright & Co. Maintain Buy Buy
2024-12-03 HC Wainwright & Co. Maintain Buy Buy
2024-11-20 HC Wainwright & Co. Maintain Buy Buy
2023-08-11 HC Wainwright & Co. Maintain Buy Buy
2023-08-11 RBC Capital Maintain Outperform Outperform
2023-08-11 Piper Sandler Maintain Overweight Overweight
2023-08-11 Oppenheimer Maintain Outperform Outperform
2023-06-12 Oppenheimer Maintain Outperform Outperform
2023-06-12 Cantor Fitzgerald Maintain Overweight Overweight
2023-06-12 HC Wainwright & Co. Maintain Buy Buy
2023-06-07 RBC Capital Maintain Outperform Outperform
2023-06-07 Piper Sandler Maintain Overweight Overweight
2023-05-09 RBC Capital Maintain Outperform Outperform
2023-05-09 Oppenheimer Maintain Outperform Outperform
2023-05-09 HC Wainwright & Co. Maintain Buy Buy
2023-03-27 Canaccord Genuity Maintain Buy Buy
2023-03-24 RBC Capital Maintain Outperform Outperform
2022-11-02 RBC Capital Maintain Outperform Outperform
2022-05-10 RBC Capital Maintain Outperform Outperform
2021-12-21 HC Wainwright & Co. Maintain Buy Buy
2021-11-12 HC Wainwright & Co. Maintain Buy Buy
2021-03-24 Oppenheimer Maintain Outperform Outperform
2020-02-20 Maxim Group Maintain Buy Buy
2020-01-09 Piper Sandler Maintain Overweight Overweight
2019-08-07 H.C. Wainwright Maintain Buy Buy
2019-01-25 Oppenheimer Maintain Outperform Outperform
2018-11-16 B. Riley FBR Maintain Buy Buy
2017-12-13 H.C. Wainwright Maintain Buy Buy
2017-09-07 H.C. Wainwright Upgrade Neutral Buy
2017-06-08 Rodman & Renshaw Maintain Neutral Neutral
2016-06-13 Roth Capital Upgrade Neutral Buy